The binding of CXCL12 to CXCR4 is said to initiate divergent signaling pathways that lead to multiple responses, including the phosphorylation of MEK/ERK signaling cascade and the activation of NF-κB, which is essential for tumor cell survival [148]. This evidence concerns the gene CXCR4 and neoplasm.